ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 624191 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 624191; 2) Community: the network communities that were significantly associated with the response to NSC 624191; 3) Molecule: the relationships between components within communities and NSC 624191; 4) MDR: the compounds that were significantly associated with the NSC 624191.

NSC Compound Enrichment Correlation
NSC 18805 .gamma.-Thujaplicine 0.013789112253851 0.44799879
NSC 269760 B8 0.013789112253851 0.25897697
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.013789112253851 0.5221748
NSC 303861 L-Cysteine analog 0.013789112253851 0.5571205
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.013789112253851 0.4169547
NSC 335995 Null 0.013789112253851 0.43096898
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.013789112253851 0.35821232
NSC 359239 Antibiotic X-14766A 0.013789112253851 0.24572491
NSC 371777 Null 0.013789112253851 0.064443328
NSC 40618 Cyclohexanone, 2,6-dibenzylidene- (8CI) 0.013789112253851 0.20868592
Total:133  Current:70    [First] [Prev] [Next] [Last]